|
Key figures for 2008 |
|||||
|
|
|
|
|
|
|
|
€ million |
Pharma- |
Chemicals |
Corporate |
Total |
Change |
|
5,428 |
2,123 |
6.6 |
7,558 |
7.1 | |
|
Gross margin |
4,485 |
1,170 |
–2.7 |
5,652 |
7.1 |
|
Research and development |
1,091 |
143 |
0 |
1,234 |
20 |
|
655 |
558 |
–81 |
1,131 |
16 | |
|
–354 |
–46 |
0 |
–400 |
–48 | |
|
Earnings before interest and tax (EBIT) |
301 |
512 |
–81 |
731 |
– |
|
EBIT before depreciation and amortization (EBITDA) |
1,381 |
645 |
–80 |
1,947 |
4.8 |
|
Return on sales in % |
12.1 |
26.3 |
– |
15.0 |
|
|
559 |
460 |
–581 |
438 |
– | |
|
Free cash flow |
598 |
474 |
–470 |
601 |
–38 |
Total revenues by business sector* |
Operating result by business sector* |
